The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

Stocks•8 May 2026•

1 min read

Invesco Acquires 5% Stake in Collegium Pharmaceutical

Key Facts

1Invesco Ltd. disclosed beneficial ownership of 1,591,909 shares of Collegium Pharmaceutical Inc., representing a 5.0% stake.

Invesco Ltd. has disclosed a new passive ownership stake in Collegium Pharmaceutical Inc., amounting to 5.0% of the company's outstanding shares. According to the Schedule 13G filing, the asset management giant now holds 1,591,909 shares in the pharmaceutical firm. This regulatory filing is mandatory when an institutional investor's position crosses the 5% ownership threshold. The move signals institutional confidence in Collegium's long-term value proposition and market position. Such accumulation by a major global asset manager is typically viewed as a bullish indicator for mid-cap stocks like COLL. Investors often monitor these filings as they reflect the sentiment of large-scale professional fund managers.

Sources: